Safer injection facilities in North America: Their place in public policy and health initiatives

Journal of Drug Issues

Volumn 32, Issue 1, 2002, Pages 329-355

  Broadhead, Robert S ^a   Kerr, Thomas H ^b,c   Grund, Jean Paul C ^d   Altice, Frederick L ^e  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b University of Victoria ^*  (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

^d UNAIDS   (Austria)

^e YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; CANADA; DRUG OVERDOSE; HEALTH PROGRAM; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION; NEEDLE; NORTH AMERICA; PATIENT COUNSELING; POLICY; REVIEW; UNITED STATES;

EID: 0036238474     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/002204260203200113     Document Type: Review

References (62)

1. The era of adherence to antiretroviral therapy
2. CT court is first in the nation to protect needle exchange from police harassment
3. Injection rooms: Places where intravenous drug use is tolerated
4. Social construction of bleach in combating AIDS among injection drug users
5. The occupational risks of harm reduction work
6. Termination of an established needle exchange: A study of claims and their impact
7. Participation in an outreach-based coupon distribution program for free methadone detoxification
8. The medical complications of drug addiction and the medical assessment of the IV drug user: Twenty-five years later
9. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia
10. Viral infections in short-term injectors: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotrophic viruses
11. Infection control basis for recommending one-time use of sterile syringes and aseptic procedures for injection drug users
12. In eastern Connecticut injectors purchase syringes from pharmacies but don’t carry syringes
13. Infectious diseases and drug abuse: Prevention and treatment in the drug abuse treatment system
14. The major medical complications of narcotic addiction
15. Safe injection facilities: Is it time?
16. Hepatitis C - Prevention and control: A public health consensus
17. Outreach in natural settings: The use of peer leaders for HIV prevention among injecting drug users’ networks
18. Experience of non-fatal overdose among heroin users in Adelaide, Australia: Circumstances and risk perceptions
19. Variations in health service use among HIV-infected patients
20. Australia allows addicts’ center to be opened in Sydney
21. Evolution of Frankfurt’s approach to the drug problem
22. Medical care for injection drug users with human immunodeficiency virus infection
23. Drug dependence: A possible new risk factor for tuberculosis disease
24. Evaluation for alley-rooms I, II and III in Basel
25. The narcotic addict as a medical patient
26. Guidelines for the operation and use of consumption rooms
27. Out-of-hospital treatment of opioid overdoses in an urban setting
28. Acute heroin overdose
29. Needle exchange is not enough: Lessons from the Vancouver injection drug use study
30. Providing medical care to methadone clinic patients: Referral vs. on-site care
31. Guest editorial: Responding to the epidemic of drug overdose death